Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas

Journal of Cellular Physiology

Volumn 210, Issue 2, 2007, Pages 370-377

  Bottoni, Arianna ^a   Zatelli, Maria Chiara ^a   Ferrcin, Manuela ^a   Tagliati, Federico ^a   Piccin, Daniela ^a   Vignali, Cristina ^a   Calin, George A ^b   Negrini, Massimo ^a   Croce, Carlo M ^b   Degli Uberti, Ettore C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; UNTRANSLATED RNA;

ADENOMA; APOPTOSIS; ARTICLE; CANCER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER RESEARCH; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MACROADENOMA; MICROADENOMA; MICROARRAY ANALYSIS; MICRORNA GENE; NEOPLASM; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE;

ADENOMA; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33845608588     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20832     Document Type: Article

References (40)

1. Ambros V. 2001. MicroRNAs: Tiny regulators with great potential. Cell 107:823-826.
2. Asa SL, Ezzat S. 1998. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798-827.
3. Asa SL, Ezzat S. 2002. The pathogenesis of pituitary tumours. Nat Rev Cancer 2: 836-849.
4. Barbareschi M, Roldo C, Zamboni G, Capelli P, Cavazza A, Macri E, Cangi MG, Chilosi M, Doglioni C. 2004. CDX-2 homeobox gene product expression in neuroendocrine tumors: Its role as a marker of intestinal neuroendocrine tumors. Am J Surg Pathol 28:1169-1176.
5. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116:281-297.
6. Billadeau DD. 2002. Cell growth and metastasis in pancreatic cancer: Is Vav the Rho'd to activation? Int J Gastrointest Cancer 31:5-13.
7. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. 2005. miR-15a and miR-16-1 downregulation in pituitary adenomas. J Cell Physiol 204:280-285.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. 2002. Frequent deletions and downregulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-15529.
9. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. 2004a. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755-11760.
10. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM. 2004b. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999-3004.
11. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. 2005. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
12. Cheng AM, Byrom MW, Shelton J, Ford LP. 2005. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290-1297.
13. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. 2005. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
14. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944-13949.
15. Croce CM, Calin GA. 2005. miRNAs, cancer, and stem cell division. Cell 122:6-7.
16. Ezzat S, Kontogeorgos G, Redelmeier DA, Horvath E, Harris AG, Kovacs K. 1995. In vivo responsiveness of morphological variants of growth hormoneproducing pituitary adenomas to octreotide. Eur J Endocrinol 133:686-690.
17. Gruszka A, Kunert-Radek J, Pawlikowski M. 2004. The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma. Folia Histochem Cytobiol 42:35-39.
18. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A. 2005. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080.
19. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070.
20. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol 12:735-739.
21. Laronde-Leblanc N, Wlodawer A. 2005. The RIO kinases: An atypical protein kinase family required for ribosome biogenesis and cell cycle progression. Biochim Biophys Acta 1754:14-24.
22. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM. 2004. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101:9740-9744.
23. Luttun A, Autiero M, Tjwa M, Carmeliet P. 2004. Genetic dissection of tumor angiogenesis: Are PIGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta 1654:79-94.
24. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA, Gittoes NJ. 2002. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 87:4238-4244.
25. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. 2004. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39:167-169.
26. Olsten ME, Canton DA, Zhang C, Walton PA, Litchfield DW. 2004. The Pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane. J Biol Chem 279: 42114-42127.
27. Pagotto U, Arzberger T, Theodoropoulou M, Grubler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK, Spengler D. 2000. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas. Cancer Res 60:6794-6799.
28. Rhoads K, Arderiu G, Charboneau A, Hansen SL, Hoffman W, Boudreau N. 2005. A role for hox a5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol 3:240-252.
29. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. 2004. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13.
30. Sethupathy P, Corda B, Hatzigeorgiou A. 2005. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 12:192-197.
31. Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. 2005. Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21:1469-1477.
32. Sorensen JB. 2005. SNARE complexes prepare for membrane fusion. Trends Neurosci 28:453-455.
33. Stegh AH, Schickling O, Ehret A, Scaffidi C, Peterhansel C, Hofmann TG, Grummt I, Krammer PH, Peter ME. 1998. DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J 17:5974-5986.
34. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756.
35. Tibshirani R, Hastie T, Narasimhan B, Chu G. 2002. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99: 6567-6572.
36. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
37. Wang DG, Johnston CF, Atkinson AB, Heaney AP, Mirakhur M, Buchanan KD. 1996. Expression of bcl-2 oncoprotein in pituitary tumours: Comparison with c-myc. J Clin Pathol 49:795-797.
38. Wang Y, Hung C, Koh D, Cheong D, Hooi SC. 2001. Differential expression of Hox A5 in human colon cancer cell differentiation: A quantitative study using real-time RT-PCR. Int J Oncol 18:617-622.
39. Xu Y, Zhang T, Tang H, Zhang S, Liu M, Ren D, Niu Y. 2005. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma. J Surg Oncol 92:326-330.
40. Zatelli MC, Piccin D, Bottoni A, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Taylor JE, Culler MD, Cavazzini L, degli Uberti EC. 2004. Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro. J Clin Endocrinol Metab 89:5181-5188.